WO2007129269A2 - Novel intermediates, process for their preparation and process for the preparation of coq10 employing the said novel intermediates - Google Patents

Novel intermediates, process for their preparation and process for the preparation of coq10 employing the said novel intermediates Download PDF

Info

Publication number
WO2007129269A2
WO2007129269A2 PCT/IB2007/051676 IB2007051676W WO2007129269A2 WO 2007129269 A2 WO2007129269 A2 WO 2007129269A2 IB 2007051676 W IB2007051676 W IB 2007051676W WO 2007129269 A2 WO2007129269 A2 WO 2007129269A2
Authority
WO
WIPO (PCT)
Prior art keywords
formula
compound
solvent
preparation
range
Prior art date
Application number
PCT/IB2007/051676
Other languages
French (fr)
Other versions
WO2007129269A3 (en
Inventor
Mita Roy
Abhay Atmaram Upare
Amit Anant Chavan
Dabeer Rauf Karnalkar
Original Assignee
Nicholas Piramal India Limited
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nicholas Piramal India Limited filed Critical Nicholas Piramal India Limited
Publication of WO2007129269A2 publication Critical patent/WO2007129269A2/en
Publication of WO2007129269A3 publication Critical patent/WO2007129269A3/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C317/00Sulfones; Sulfoxides
    • C07C317/16Sulfones; Sulfoxides having sulfone or sulfoxide groups and singly-bound oxygen atoms bound to the same carbon skeleton
    • C07C317/18Sulfones; Sulfoxides having sulfone or sulfoxide groups and singly-bound oxygen atoms bound to the same carbon skeleton with sulfone or sulfoxide groups bound to acyclic carbon atoms of the carbon skeleton
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C315/00Preparation of sulfones; Preparation of sulfoxides
    • C07C315/04Preparation of sulfones; Preparation of sulfoxides by reactions not involving the formation of sulfone or sulfoxide groups
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C46/00Preparation of quinones
    • C07C46/02Preparation of quinones by oxidation giving rise to quinoid structures
    • C07C46/06Preparation of quinones by oxidation giving rise to quinoid structures of at least one hydroxy group on a six-membered aromatic ring

Definitions

  • Coenzyme QlO or CoQlO has the chemical name 2- [(all -trans)- 3, 7,ll,15,19,23,27,31,35,39-decamethyl-2, 6, 10, 14, 18, 22, 26, 30, 34, 38 - tetracontadecaenylJ-S ⁇ -dimethoxy -3- methyl -1,4-benzoquinone and has the formula 1.
  • the invention also provides new intermediates useful for the preparation of CoQlO and processes for their preparation.
  • This coenzyme is present in virtually every cell in the human body and is known as the "miracle nutrient”. It plays a vital role in maintaining human health and vigor and is involved in mitochondrial processes such as respiration, maintenance of heart muscle strength, enhancement of the immune system, quenching of free radical in the battle against ageing to name a few ("The miracle nutrient coenzyme” Elsevier/ North - Holland Biomedical Press, New York, 1986; “Coenzyme Q: Biochemistry, Bioenergetics, and clinical Applications of Ubiquinone” Wiley, New York, 1985; “ Coenzyme Q, Molecular Mechanism in Health and Disease” CRC press).
  • CoQlO of the formula 1 comprises mainly of two moieties (i) the head group - "benzoquinone nucleus” and (ii) the "polyprenyl side chain” with ten isoprene units.
  • the source of benzoquinone nucleus is 2,3-dimethoxy-5-methyl benzoquinone, CoQO 1 of the formula 2.
  • the source of the polyprenyl side chain is solanesol, a naturally occurring alcohol, containing nine isoprene units and having the formula 3.
  • the key step in the synthesis of CoQlO is in the addition of the remaining isoprene unit.
  • Literature method of synthesis of chloroisoprenyl sulphone compound of formula 5 is by heating isoprene of formula 4 (0.0846 mmols), benzene sulphonyl chloride (0.086 mmols), cuprous chloride (0.846 mmols) and triethyl amine hydrochloride (0.086 mmols) in acetonitrile (0.079 mols), at reflux temperature for 2 hours and quenching in cold methanol.
  • the crude product of formula 5 is recrystallized from 95% ethanol to obtain compound of formula 5 in 42% yield (J. Org. Chem. 35,4217(1970).
  • Chloroisoprenyl sulphone compound of formula 5 is reacted with "benzoquinone nucleus" compound of formula 6 where R is protecting group to form CoQ 1 sulphone of formula 7.
  • Compound of formula 6 is made from CoQ o compound of formula 2 in three steps.
  • CoQl sulphone compound of formula 7 is reacted with solanesyl bromide to form CoQlO sulphone, compound of formula 8, which is desulphonated to form compound of formula 9 followed by deprotection and oxidation to form CoQlO of formula 1.
  • Desulphonation of compound of formula 8 where R is -CH 2 OCH 2 CH 2 OCH 3 or -CH 3 uses modified Bouvelut-Blanc method of sodium and ethanol and THF as solvent, at 10-12 0 C.
  • Deprotection involves (i) 48% hydrobromic acid at 50 0 C, (ii) Methanolic Hydrochloric acid (BuU.Chem.Soc. Japan, 55, 1325 (1982)).
  • the critical parameter associated with the synthesis of CoQlO involving the above route is selection of protecting groups that can be (i) synthesized cost effectively, (ii) deprotected easily under mild condition and (iii) oxidized readily.
  • the synthesis of compound of formula 6 where R is -CH 2 OCH 2 CH 2 OCH 3 requires methoxyethoxymethyl chloride. Methoxyethoxymethyle chloride is a costly reagent and the requirement of two equivalents per one equivalent of the compound adds to the cost.
  • the present inventors observed that the oxidation also results in side reactions with yield loss and therefore is not cost effective.
  • CoQlO Use of CoQlO in broadband medical application is increasing day by day.
  • the key point in the synthesis of CoQlO is the choice of the building blocks of i)"isoprene unit", (ii) "the benzoquinone nucleus” and (iii) "the polyprenyl side chain".
  • a cost effective process of preparing CoQlO can be made only with the suitable "building blocks" which are made economically. An industrially viable process is currently lacking.
  • the present invention disclosed in this application relates to an improved process for the preparation of CoQlO 1 by condensation of one isoprene unit to the head group "benzoquinone nucleus" to form novel intermediate CoQ 1, which is coupled with solanesyl bromide.
  • the main objective of the present invention is to provide an improved process for the preparation of CoQlO of the formula 1, given herein above and overcoming the drawbacks of the hitherto known processes.
  • Another objective of the present invention is to provide an improved process for the preparation of CoQlO of the formula 1 given herein above which is useful for industrial application.
  • Another objective of the present invention is to provide a novel intermediate, namely, CoQl sulphone of the formula 11 which is also useful for the preparation of CoQlO
  • Another objective of the present invention is to provide a novel intermediate, namely, CoQlO sulphone of the formula 12 useful for the preparation of CoQlO
  • Still another objective of the present invention is to provide a process for the preparation of novel intermediate namely, CoQi sulphone of the formula 12 which is simple, cost effective and commercially applicable.
  • the present invention for the preparation of CoQlO has been developed based on using chloroisoprene sulphone as building block of one isoprene unit, using protecting groups such as methoxyethoxy methyl and methyl groups to form the building block of benzoquinone nucleus, and solanesyl bromide as a building block with nine isoprene units.
  • the present invention provides a process for the preparation of CoQ 10 of the formula 1
  • said process comprising the steps of: i. reacting the Grignard reagent of formula 10 (as described herein below) with chloroisoprenyl sulphone of formula 5 in the presence of a copper salt and a solvent under inert atmosphere, at a temperature in the range of
  • Chloroisoprenyl sulphone of the formula 5 may be obtained by reacting isoprene with benzenesulphonyl chloride and triethylamine hydrochloride in presence of cuprous halide preferably cuprous iodide at a temperature in the range of 40 0 C to 60 ° C in acetonitrile, quenching the resultant reaction, extracting the product with a chlorinated solvent, and evaporating the solvent
  • CoQ 1 sulphone of the formula 11 may be obtained by coupling the Grignard reagent 10 with chloroisoprenyl sulphone 5 in the presence of cuprous salt such as cuprous chloride, cuprous iodide, cuprous sulfate and the like; a solvent such as diethylether, tetrahydrofuan, dioxan and the like at a temperature in the range of -25°C to 40 0 C for a period of 2 to 4 hours.
  • the Grignard reagent may be prepared by any known method as well by the method described in our co-pending India patent application No. 805/MUM/2005.
  • the molar ratio of cuprous salt to the Grignard reagent used may vary from 1:0.1 to 1:1.0, preferably 1:0.7.
  • the condensation of solanesyl bromide of formula 3a with CoQ 1 sulphone compound of the formula 11 may be carried out in the presence of a base such as potassium tertiary butoxide, sodium ethoxide, sodium hydroxide, potassium hydroxide and the like; solvent such as N,N-dimethyl formamide, tetrahydrofuran, diisopropyl ether and the like at a temperature in the range of -50 0 C to 50 0 C for period of 1 to 6 hours. Purification at this stage is not needed and proceeded to the next step of desulphonation thereby further making the process not only simple but also cost effective for commercial production.
  • a base such as potassium tertiary butoxide, sodium ethoxide, sodium hydroxide, potassium hydroxide and the like
  • solvent such as N,N-dimethyl formamide, tetrahydrofuran, diisopropyl ether and the like
  • the desulphonation of the compound of the formula 11 to obtain compound of formula 12 may be carried out by using sodium and ethanol in an inert solvent such as tetrahydrofuran, diethylether, xylol and the like at a temperature in the range of -40 0 C to 20 0 C for a period of 16 to 24 hours.
  • an inert solvent such as tetrahydrofuran, diethylether, xylol and the like at a temperature in the range of -40 0 C to 20 0 C for a period of 16 to 24 hours.
  • Deprotection of the compound of the formula 12 to get the compound of the formula 13 may be carried out using 48% hydrogen bromide solution or with a mild Lewis acid preferably zinc halide, such as zinc chloride, zinc bromide and the like in a chlorinated solvent such as methylene chloride, chloroform or carbon tetrachloride at a temperature in the range of 15 0 C to 50 0 C for a period of 2 to 6 hours.
  • Zinc halide may be used in the molar ratio of 1:1 to 1:5.
  • the oxidation of the formula 13 may carried out by known method of using Ferric chloride in isopropanol,
  • Preparation of chloroisoprenyl sulphone compound of formula 5 may be carried out by reacting benzene sulphonyl chloride with isoprene in presence of triethylamine hydrochloride in acetonitrile.
  • the molar ratio of benzene sulphonyl chloride and isoprene may be taken in the range of 1:1 to 1:2 preferably 1:1.2 to 1:1.3.
  • Molar ratio of benzene sulphonyl chloride to triethylamine hydrochloride may be varied from 1:01 to 1:0.2 preferably 1:0.08 to 1:0.15.
  • Catalyst used for the reaction may be cuprous iodide.
  • Molar ratio of benzene sulphonyl chloride to cuprous iodide may be varied from 1:0.01 to 1:0.05 preferably 1:0.02 to 1:0.03. Reaction may be quenched in ammonium chloride solution and the product extracted in chlorinated hydrocarbon solvent. The solvent may be evaporated and the product compound of formula 5 may be isolated in alcohol preferably methanol or isopropanol. Unlike the prior art, the present invention utilizes benzene sulphonyl chloride and isoprene in a ratio of 1:1.2 to 1:1.3 and cuprous iodide as a catalyst, which results in higher yield and better purity.
  • Benzene sulphonyl chloride 50 g , isoprene 31.5 g , cuprous iodide 1.0 g, triethylamine hydrochloride 7.8 g were taken in acetonitrile 135 ml and heated to 50 - 60 0 C for 15 hrs. The reaction was diluted with methylene dichloride and washed with aqueous ammonium chloride solution. The methylene dichloride layer was dried over anhydrous sodium sulphate, filtered and evaporated under vacuum. Methanol was added to the residue to precipitate the solid (41 g , HPLC 83%)
  • Benzene sulphonyl chloride 50 g, isoprene 23 g, cuprous iodide 1.0 g, triethylamine hydrochloride 3.9 g were taken in acetonitrile 135 ml and heated to 50 -60 ° C for 15 hrs. The reaction was diluted with methylene dichloride and washed with aqueous ammonium chloride solution. The methylene dichloride layer was dried over anhydrous sodium sulphate, filtered and evaporated under vacuum . Methanol was added to the residue to precipitate the solid (64 g) which was purified in isopropanol to obtain compound of formula 5 (32 g, HPLC 97%)
  • step (i) above Cooled the reaction mixture obtained in step (i) above to 15 to 20 0 C and was added anhydrous cuprous chloride 2Og, followed by chloroisoprenyl sulphone 70 g in THF
  • Dissolved Solanesyl bromide 222 g prepared by the process given in literature in THF 700 ml.
  • Dissolved compound of formula 11 (190 g) prepared by the process described in Example 5 in THF (1.0 litre) and DMF (190 ml) and added to the solution of solanesyl bromide. Cooled the reaction mixture to - 30 ° C to - 35° C.
  • To the reaction mixture was added potassium tertiary butoxide solution 40.5g in 300 ml THF over a period of 20 minutes at - 30 ° C to - 35° C. Maintained for 1.0 hour at - 20 0 C to - 30 ° C and raised the contents of the flask to room temperature.
  • Dissolved Solanesyl bromide 222 g prepared by the process given in literature in THF 700 ml.
  • Dissolved compound of formula 11 (190 g ) prepared by the process described in Example 5 in THF (1.0 litre) and DMF (190 ml) and added to the solution of solanesyl bromide. Cooled the reaction mixture to - 30 ° C to - 35° C.
  • To the reaction mixture was added potassium tertiary butoxide 46.7 g at - 30 ° C to - 35° C. Maintained for 1.0 hour at -20 0 C to - 30 ° C and raised the contents of the flask to room temperature.

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

The present invention relates to an improved process for the preparation of Coenzyme Q. Coenzyme QlO or CoQlO has the chemical name 2- [(all -trans)- 3, 7,l l,15,19,23,27,31,35,39-decamethyl-2, 6, 10, 14, 18, 22, 26, 30, 34, 38 - tetracontadecaenyl]-5-6-dimethoxy -3- methyl -1,4-benzoquinone and has the formula 1. The invention also provides new intermediates useful for the preparation of CoQlO and processes for their preparation.

Description

NPCQE_07
NOVEL INTERMEDIATES, PROCESS FOR THEIR PREPARATION AND PROCESS FOR THE PREPARATION OF CoQlO EMPLOYING THE SAID
NOVEL INTERMEDIATES
Field of Invention
The present invention relates to an improved process for the preparation of Coenzyme Q. Coenzyme QlO or CoQlO has the chemical name 2- [(all -trans)- 3, 7,ll,15,19,23,27,31,35,39-decamethyl-2, 6, 10, 14, 18, 22, 26, 30, 34, 38 - tetracontadecaenylJ-S^-dimethoxy -3- methyl -1,4-benzoquinone and has the formula 1.
side chain
Figure imgf000002_0001
1
The invention also provides new intermediates useful for the preparation of CoQlO and processes for their preparation.
Background of the Invention
This coenzyme is present in virtually every cell in the human body and is known as the "miracle nutrient". It plays a vital role in maintaining human health and vigor and is involved in mitochondrial processes such as respiration, maintenance of heart muscle strength, enhancement of the immune system, quenching of free radical in the battle against ageing to name a few ("The miracle nutrient coenzyme" Elsevier/ North - Holland Biomedical Press, New York, 1986; "Coenzyme Q: Biochemistry, Bioenergetics, and clinical Applications of Ubiquinone" Wiley, New York, 1985; " Coenzyme Q, Molecular Mechanism in Health and Disease" CRC press).
As depicted above CoQlO of the formula 1 comprises mainly of two moieties (i) the head group - "benzoquinone nucleus" and (ii) the "polyprenyl side chain" with ten isoprene units. The source of benzoquinone nucleus is 2,3-dimethoxy-5-methyl benzoquinone, CoQO1 of the formula 2.
Figure imgf000003_0001
The source of the polyprenyl side chain is solanesol, a naturally occurring alcohol, containing nine isoprene units and having the formula 3. The key step in the synthesis of CoQlO is in the addition of the remaining isoprene unit.
Figure imgf000003_0002
One of the processes given in literature for the addition of the remaining isoprene unit is to modify isoprene compound of formula 4 to an active building block of "chloroisoprenyl sulphone " compound of formula 5.
Figure imgf000003_0003
4 5
Literature method of synthesis of chloroisoprenyl sulphone compound of formula 5 is by heating isoprene of formula 4 (0.0846 mmols), benzene sulphonyl chloride (0.086 mmols), cuprous chloride (0.846 mmols) and triethyl amine hydrochloride (0.086 mmols) in acetonitrile (0.079 mols), at reflux temperature for 2 hours and quenching in cold methanol. The crude product of formula 5 is recrystallized from 95% ethanol to obtain compound of formula 5 in 42% yield (J. Org. Chem. 35,4217(1970).
The present inventors have observed that following the above procedure the reaction does not go to completion under the above condition and results in poor yield (30- 40%) of the crude product.
In another method, benzenesulphonyl chloride (50 mmol), isoprene (100 mmol), cuprous chloride (2.5 mmol) and triethylamine hydrochloride (2.5 mmol), were heated to 60° C for 15 hours, cooled and quenched in methylene dichloride. The compound of formula 5 was isolated by distilling out solvent and crystallizing in 95% ethanol in 90% yield (J. Org. Chem. 68, 7925(2003)). Both the processes as mentioned herein above do not mention about the positional isomers of compound of formula 5a and cis isomer of compound of formula 5b, that are formed during the synthesis (J. Org. Chem. 41 3287(1976)).
Figure imgf000004_0001
5a 5b
As reported in J.Org.Chem.41 3287 (1976), total yield of 95% is obtained for the mixture of all the three compounds of formula 5, 5a and 5b respectively. Mixture of 5 and 5a in the ratio of 4:1 is obtained in 74 % yield. Purification of the desired compound 5 from the crude is obtained with drastic yield loss in 33.5 % yield only (J. Org. Chem. 41 3287(1976)).
Thus an industrially economical process in which the formation of the unwanted isomers is minimized is presently lacking.
Chloroisoprenyl sulphone compound of formula 5 is reacted with "benzoquinone nucleus" compound of formula 6 where R is protecting group to form CoQ1 sulphone of formula 7. Compound of formula 6 is made from CoQ o compound of formula 2 in three steps.
Choice of protecting group is a major contributing factor in the synthesis of CoQlO. The protecting groups used in literature for the synthesis of CoQlO using chloroisoprenyl sulphone of formula 5 are -CH2OCH2CH2OCH 3 and -CH3 respectively.
Figure imgf000004_0002
CoQl sulphone compound of formula 7 is reacted with solanesyl bromide to form CoQlO sulphone, compound of formula 8, which is desulphonated to form compound of formula 9 followed by deprotection and oxidation to form CoQlO of formula 1.
Figure imgf000005_0001
Desulphonation of compound of formula 8 where R is -CH2OCH2CH2OCH3 or -CH3 uses modified Bouvelut-Blanc method of sodium and ethanol and THF as solvent, at 10-120C.
Deprotection involves (i) 48% hydrobromic acid at 500C, (ii) Methanolic Hydrochloric acid (BuU.Chem.Soc. Japan, 55, 1325 (1982)).
The critical parameter associated with the synthesis of CoQlO involving the above route is selection of protecting groups that can be (i) synthesized cost effectively, (ii) deprotected easily under mild condition and (iii) oxidized readily. The synthesis of compound of formula 6 where R is -CH2OCH2CH2OCH3 requires methoxyethoxymethyl chloride. Methoxyethoxymethyle chloride is a costly reagent and the requirement of two equivalents per one equivalent of the compound adds to the cost.
Deprotection of the two methoxyethoxymethyl groups in compound of formula 9 where R is-CH2OCH2CH2 OCH3 also requires drastic condition for deprotection that leads to impurity formation. The synthesis of CoQlO from compound of formula 9 where R is -CH3 requires expensive reagent of eerie ammonium nitrate for oxidation step (J. Org. Chem. 68,
7925 (2003)).
The present inventors observed that the oxidation also results in side reactions with yield loss and therefore is not cost effective.
Use of CoQlO in broadband medical application is increasing day by day. The key point in the synthesis of CoQlO is the choice of the building blocks of i)"isoprene unit", (ii) "the benzoquinone nucleus" and (iii) "the polyprenyl side chain". A cost effective process of preparing CoQlO can be made only with the suitable "building blocks" which are made economically. An industrially viable process is currently lacking.
Keeping the above facts in mind, the present inventors have explored various alternatives for the preparation of CoQlO. The present inventors have developed the following improved novel processes and novel intermediates
1. Improved process for the preparation of the "benzoquinone nucleus" - the head group of CoQlO. The process has also resulted in producing novel intermediates. These aspects have been made the subject of our co-pending Indian patent application No. 803/MUM/2005
2. Improved processes for the preparation of solanesyl bromide and solanesyl acetone, the key intermediates for the preparation of the "polyprenyl side chain" of CoQlO. Such processes have been made the subject matter of our co-pending Indian patent application No. 804/MUM/2005
3. Improved process for the preparation of CoQlO, by coupling of the polyprenyl side chain of ten isoprene units, with the head group "benzoquinone nucleus". Such scheme of synthesis has been made the subject matter of our co-pending Indian patent application No. 805/MUM/2005 4. An improved process for the preparation of CoQlO1 by condensation of one isoprene unit to the head group "benzoquinone nucleus" to form novel intermediate CoQi1 which is coupled with solanesyl bromide. Such scheme of synthesis has been made the subject matter of our co-pending Indian patent application No. 806/MUM/2005 The present invention disclosed in this application relates to an improved process for the preparation of CoQlO1 by condensation of one isoprene unit to the head group "benzoquinone nucleus" to form novel intermediate CoQ1, which is coupled with solanesyl bromide.
Objective of the invention
The main objective of the present invention is to provide an improved process for the preparation of CoQlO of the formula 1, given herein above and overcoming the drawbacks of the hitherto known processes.
Another objective of the present invention is to provide an improved process for the preparation of CoQlO of the formula 1 given herein above which is useful for industrial application.
Another objective of the present invention is to provide a novel intermediate, namely, CoQl sulphone of the formula 11 which is also useful for the preparation of CoQlO
Figure imgf000007_0001
Another objective of the present invention is to provide a novel intermediate, namely, CoQlO sulphone of the formula 12 useful for the preparation of CoQlO
Figure imgf000007_0002
Still another objective of the present invention is to provide a process for the preparation of novel intermediate namely, CoQi sulphone of the formula 12 which is simple, cost effective and commercially applicable.
Yet another objective of the present invention is to provide a process for the preparation of novel intermediate namely CoQlO sulphone of the formula 12 wherein the yield is 80% and the purity is 98%, useful for the preparation of CoQlO . Yet another objective of the present invention is to provide an improved process for the preparation of chloroisoprenyl sulphone compound of formula 5
Figure imgf000008_0001
Detailed Description of the Invention
The present invention for the preparation of CoQlO has been developed based on using chloroisoprene sulphone as building block of one isoprene unit, using protecting groups such as methoxyethoxy methyl and methyl groups to form the building block of benzoquinone nucleus, and solanesyl bromide as a building block with nine isoprene units.
Accordingly, the present invention provides a process for the preparation of CoQ 10 of the formula 1
Figure imgf000008_0002
said process comprising the steps of: i. reacting the Grignard reagent of formula 10 (as described herein below) with chloroisoprenyl sulphone of formula 5 in the presence of a copper salt and a solvent under inert atmosphere, at a temperature in the range of
-25° C to 40° C for a period of 2 to 4 hours, quenching the resultant reaction, extracting the product with a water immiscible solvent to give compound of formula 11, 11. condensing compound of formula ll_with solanesyl bromide of formula 3a in the presence of a base and a solvent at a temperature in the range of - 500C to 500C for a period of 1 to 6 hours to obtain compound of formula 12,
111. desulphonating the compound of the formula 12 using sodium/ethanol in an inert solvent at a temperature in the range of -400C to 200C for a period of 16 to 24 hours to obtain the compound of formula 13,
IV. deprotecting the compound of the formula 13j by HBr or zinc halide / acetic acid in the presence of a chlorinated solvent at a temperature in the range of 15°C to 500C for a period of 2 to 6 hours, quenching the reaction mixture in aqueous medium and extracting the resulting mixture by a water immiscible solvent, evaporating the solvent to obtain the compound of formula 14, v. oxidising the compound of formula 14 by conventional method to form compound of formula 1 and
Vl. isolating the compound of formula (1) formed by conventional methods. The process explained above is shown in scheme- 1 below:
Figure imgf000009_0001
Chloroisoprenyl sulphone of the formula 5 may be obtained by reacting isoprene with benzenesulphonyl chloride and triethylamine hydrochloride in presence of cuprous halide preferably cuprous iodide at a temperature in the range of 400C to 60 ° C in acetonitrile, quenching the resultant reaction, extracting the product with a chlorinated solvent, and evaporating the solvent
CoQ1 sulphone of the formula 11 may be obtained by coupling the Grignard reagent 10 with chloroisoprenyl sulphone 5 in the presence of cuprous salt such as cuprous chloride, cuprous iodide, cuprous sulfate and the like; a solvent such as diethylether, tetrahydrofuan, dioxan and the like at a temperature in the range of -25°C to 400C for a period of 2 to 4 hours. The Grignard reagent may be prepared by any known method as well by the method described in our co-pending India patent application No. 805/MUM/2005. The molar ratio of cuprous salt to the Grignard reagent used may vary from 1:0.1 to 1:1.0, preferably 1:0.7.
The condensation of solanesyl bromide of formula 3a with CoQ1 sulphone compound of the formula 11 may be carried out in the presence of a base such as potassium tertiary butoxide, sodium ethoxide, sodium hydroxide, potassium hydroxide and the like; solvent such as N,N-dimethyl formamide, tetrahydrofuran, diisopropyl ether and the like at a temperature in the range of -500C to 500C for period of 1 to 6 hours. Purification at this stage is not needed and proceeded to the next step of desulphonation thereby further making the process not only simple but also cost effective for commercial production.
The desulphonation of the compound of the formula 11 to obtain compound of formula 12 may be carried out by using sodium and ethanol in an inert solvent such as tetrahydrofuran, diethylether, xylol and the like at a temperature in the range of -400C to 200C for a period of 16 to 24 hours.
Deprotection of the compound of the formula 12 to get the compound of the formula 13 may be carried out using 48% hydrogen bromide solution or with a mild Lewis acid preferably zinc halide, such as zinc chloride, zinc bromide and the like in a chlorinated solvent such as methylene chloride, chloroform or carbon tetrachloride at a temperature in the range of 150C to 500C for a period of 2 to 6 hours. Zinc halide may be used in the molar ratio of 1:1 to 1:5. The oxidation of the formula 13 may carried out by known method of using Ferric chloride in isopropanol,
According to an embodiment of the present invention there is provided an improved process for the preparation of chloroisoprenyl sulphone compound of formula 5
Figure imgf000011_0001
useful for the preparation of CoQ10, said process comprising the steps of:
(i) Reacting isoprene of formula 4
Figure imgf000011_0002
4 with benzenesulphonyl chloride and triethylamine hydrochloride in presence of cuprous halide preferably cuprous iodide at a temperature in the range of 400C to 60 ° C in acetonitrile, quenching the resultant reaction mixture, extracting the product with a chlorinated solvent, evaporating the solvent to give compound of formula 5,
(ii) isolating and purifying the compound of formula 5 by conventional methods.
Preparation of chloroisoprenyl sulphone compound of formula 5 may be carried out by reacting benzene sulphonyl chloride with isoprene in presence of triethylamine hydrochloride in acetonitrile. The molar ratio of benzene sulphonyl chloride and isoprene may be taken in the range of 1:1 to 1:2 preferably 1:1.2 to 1:1.3. Molar ratio of benzene sulphonyl chloride to triethylamine hydrochloride may be varied from 1:01 to 1:0.2 preferably 1:0.08 to 1:0.15. Catalyst used for the reaction may be cuprous iodide. Molar ratio of benzene sulphonyl chloride to cuprous iodide may be varied from 1:0.01 to 1:0.05 preferably 1:0.02 to 1:0.03. Reaction may be quenched in ammonium chloride solution and the product extracted in chlorinated hydrocarbon solvent. The solvent may be evaporated and the product compound of formula 5 may be isolated in alcohol preferably methanol or isopropanol. Unlike the prior art, the present invention utilizes benzene sulphonyl chloride and isoprene in a ratio of 1:1.2 to 1:1.3 and cuprous iodide as a catalyst, which results in higher yield and better purity.
According to yet another embodiment of the present invention there is provided a novel intermediate of formula 11
Figure imgf000012_0001
which is useful for the preparation of CoQlO.
According to yet another embodiment of the present invention there is provided a process for the preparation of novel intermediate of the formula 11
Figure imgf000012_0002
which is useful for the preparation of CoQlO, said process comprising the steps of: (i) reacting the Grignard reagent of formula 10
Figure imgf000012_0003
with chloroisoprenyl sulphone of formula 5
Figure imgf000012_0004
in the presence of copper salt and a solvent under inert atmosphere, at a temperature in the range of -25° C to 40° C for a period of 2 to 4 hours, quenching the resultant reaction, extracting the product with a water immiscible solvent to give compound of formula 11,
(ii) isolating and purifying the compound of formula 11 formed by conventional methods.
According to yet another embodiment of the present invention there is provided a novel intermediate of formula 12
Figure imgf000013_0001
which is useful for the preparation of CoQlO.
According to another embodiment of the present invention, there is provided a process for the preparation of the novel intermediate compound of the formula 12
Figure imgf000013_0002
which is useful for the preparation of CoQlO, said process comprising the steps of: (i) condensing compound of formula 11
Figure imgf000013_0003
with solanesyl bromide of formula 3a
Figure imgf000014_0001
in the presence of a base and a solvent at a temperature in the range of -500C to 500C for a period of 1 to 6 hours, quenching the resultant reaction, extracting the product with a water immiscible solvent to give compound of formula 12
(ii) isolating and purifying the compound of formula 12 formed by conventional methods.
The details of the various reactions conditions of the processes described above and those preferred ones are given below. The details of the process of the present invention are given in the Examples below which are provided for illustration only and therefore they should not be construed to limit the scope of the invention
Example 1 Preparation of Chloroisoprenyl Sulphone compound of formula 5
Benzene sulphonyl chloride 50 g , isoprene 31.5 g , cuprous iodide 1.0 g, triethylamine hydrochloride 7.8 g were taken in acetonitrile 135 ml and heated to 50 - 600C for 15 hrs. The reaction was diluted with methylene dichloride and washed with aqueous ammonium chloride solution. The methylene dichloride layer was dried over anhydrous sodium sulphate, filtered and evaporated under vacuum. Methanol was added to the residue to precipitate the solid (41 g , HPLC 83%)
Example 2
Preparation of Chloroisoprenyl Sulphone compound of formula 5 Benzene sulphonyl chloride 50 g , isoprene 23 g , cuprous iodide 1.0 g, triethylamine hydrochloride 3.9 g were taken in acetonitrile 135 ml and heated to 50 -60 ° C for 15 hrs. The reaction was diluted with methylene dichloride and washed with aqueous ammonium chloride solution. The methylene dichloride layer was dried over anhydrous sodium sulphate, filtered and evaporated under vacuum . Methanol was added to the residue to precipitate the solid (62 g , HPLC 83%) Example 3
Preparation of Chloroisoprenyl Sulphone of formula 5
Benzene sulphonyl chloride 50 g, isoprene 23 g, cuprous iodide 1.0 g, triethylamine hydrochloride 3.9 g were taken in acetonitrile 135 ml and heated to 50 -60 ° C for 15 hrs. The reaction was diluted with methylene dichloride and washed with aqueous ammonium chloride solution. The methylene dichloride layer was dried over anhydrous sodium sulphate, filtered and evaporated under vacuum . Methanol was added to the residue to precipitate the solid (64 g) which was purified in isopropanol to obtain compound of formula 5 (32 g, HPLC 97%)
Example 4
Preparation of compound of formula 11 (i) Preparation of Grignard reagent of formula 10 Suspended 12 g of magnesium in tetrahydrofuran 550 ml and heated to 40 - 450C. Then, added a pinch of iodine and 2,3,4-trimethoxy-5-bromo-6-methylhydroquinone methoxyethoxymethyl ether 150 g slowly until initiation of Grignard reagent takes place. After completion of addition maintained the reaction for 2.0 hrs at the same temperature, (ii) Preparation of COQl of formula 11 Cooled the reaction mixture obtained in step (i) above to 15 to 20 0C and was added anhydrous cuprous chloride 40 g, followed by chloroisoprenyl sulphone 70.0 g in THF 800 ml, maintained the reaction at the same temperature for 3.0 hrs and quenched the reaction in ammonium chloride and extracted the product in isopropyl ether, washed the isopropyl ether layer with water, saturated sodium chloride solution and dried under sodium sulphate and distilled isopropyl ether under vacuum at 500C to get COQl crude. The crude was purified by column chromatography to yield 113 g (80% of theory, HPLC 98%) of compound of formula 11
Example 5 Preparation of compound of formula 11
(i) Preparation of Grignard reagent of formula 10
Suspended 12 g of magnesium in tetrahydrofuran 550 ml and heated to 40 - 45°C. Then, added a pinch of iodine and 2,3,4-trimethoxy-5-bromo-6-methylhydroquinone methoxyethoxymethyl ether 131 g slowly until initiation of Grignard reagent takes place. After completion of addition maintained the reaction for 2.0 hrs at the same temperature.
(ii) Preparation of COQl of formula 11
Cooled the reaction mixture obtained in step (i) above to 15 to 20 0C and was added anhydrous cuprous chloride 2Og, followed by chloroisoprenyl sulphone 70 g in THF
800 ml, maintained the reaction at the same temperature for 3.0 hrs and quenched the reaction in ammonium chloride and extracted the product in isopropyl ether, washed the isopropyl ether layer with water, saturated sodium chloride solution and dried under sodium sulphate and distilled isopropyl ether under vacuum at 500C to get COQl crude. The crude was purified by column chromatography to yield 106 g (75 % of theory, HPLC 98%) of compound of formula IL
Example 6
Preparation of compound of formula 12 Dissolved Solanesyl bromide 222 g prepared by the process given in literature in THF 700 ml. Dissolved compound of formula 11 (190 g) prepared by the process described in Example 5 in THF (1.0 litre) and DMF (190 ml) and added to the solution of solanesyl bromide. Cooled the reaction mixture to - 30 ° C to - 35° C. To the reaction mixture was added potassium tertiary butoxide 40.5g at - 30 ° C to - 35° C. Maintained for 1.0 hour at -200C to - 30 ° C and raised the contents of the flask to room temperature. Reaction was continued for 1.0 hour at the same temperature and quenched in ammonium chloride solution. The product was extracted with hexane, dried over anhydrous sodium sulphate and distilled under vacuum at 500C to obtain a pale yellow viscous oil of compound of formula 12. Yield 325 g (92 %, HPLC purity 88 %).
Example 7
Preparation of compound of formula 12
Dissolved Solanesyl bromide 222 g prepared by the process given in literature in THF 700 ml. Dissolved compound of formula 11 (190 g) prepared by the process described in Example 5 in THF (1.0 litre) and DMF (190 ml) and added to the solution of solanesyl bromide. Cooled the reaction mixture to - 30 ° C to - 35° C. To the reaction mixture was added potassium tertiary butoxide solution 40.5g in 300 ml THF over a period of 20 minutes at - 30 ° C to - 35° C. Maintained for 1.0 hour at - 200C to - 30 ° C and raised the contents of the flask to room temperature. Reaction was continued for r 1.0 hour at the same temperature and quenched in ammonium chloride solution. The product was extracted with hexane, dried over anhydrous sodium sulphate and distilled under vacuum at 500C to obtain a pale yellow viscous oil of compound of formula 12_Yield 327 g (92 %, HPLC purity 88 %).
Example 8
Preparation of compound of formula 12
Dissolved Solanesyl bromide 222 g prepared by the process given in literature in THF 700 ml. Dissolved compound of formula 11 (190 g ) prepared by the process described in Example 5 in THF (1.0 litre) and DMF (190 ml) and added to the solution of solanesyl bromide. Cooled the reaction mixture to - 30 ° C to - 35° C. To the reaction mixture was added potassium tertiary butoxide 46.7 g at - 30 ° C to - 35° C. Maintained for 1.0 hour at -200C to - 30 ° C and raised the contents of the flask to room temperature. Reaction was continued for r 1.0 hour at the same temperature and quenched in ammonium chloride solution. The product was extracted with hexane, dried over anhydrous sodium sulphate and distilled under vacuum at 500C to obtain a pale yellow viscous oil of compound of formula 12. Yield 301g (85 %, HPLC purity 88 %).
Example 9
Preparation of compound of formula 1
Compound of formula 12 prepared by the process described in Example 8 (200 g) was taken in THF 1.0 litre and cooled to -25°C to - 300C. Ethanol 108 g and sodium 3 Ig was added at -25°C to - 300C. Reaction was maintained for 22 hrs at the same temperature. Excess sodium in the reaction mixture was destroyed by adding methanol and the reaction mixture quenched in ammonium chloride solution and extracted with hexane. Hexane layer was dried over anhydrous sodium sulphate and distilled under vacuum at 500C. The residue obtained was purified by column chromatography to yield 137 g of compound of formula 13_(Yield 69 % , Purity 99 %). Dissolved compound of formula 13 in 685 ml methylene chloride . Zinc bromide (159.7 g) was added and stirred at room temperature for 3 hours. After completion of reaction filtered the reaction mass, and neutralised with sodium bicarbonate solution. The organic layer was distilled under vacuum to obtain compound of formula 14 as a viscous oil (130 g). The compound of formula 14 was dissolved in isopropyl alcohol 1300 ml and oxidized using ferric chloride 146.7 g in water 74 ml. The reaction mixture was stirred for ό.Ohours at 40-450C and quenched with water and extracted with hexane. The hexane layer was dried over anhydrous sodium sulphate, filtered and distilled under vacuum to obtain compound of formula 1 a dark red viscous oil, which was dissolved in isopropanol at 500C and cooled slowly to 100C to get a pale yellow solid which was filtered and washed with sufficient quantity of IPA.
Example 10 Preparation of compound of formula 1
Compound of formula 12 prepared by the process described in Example 8 (200 g) was taken in THF 1.0 litre and cooled to -25°C to - 300C. Ethanol 108 g and sodium 31g was added at -250C to - 300C. Reaction was maintained for 22 hrs at the same temperature. Excess sodium in the reaction mixture was destroyed by adding methanol and the reaction mixture quenched in ammonium chloride solution and extracted with hexane. Hexane layer was dried over anhydrous sodium sulphate and distilled under vacuum at 500C. The residue obtained was purified by column chromatography to yield 137 g of compound of formula 13_(Yield 69 %, Purity 99 %). Dissolved compound of formula 13 (100 g) in 1.0 lit isopropyl alcohol and added catalytic quantity of cone. HBr warmed to 500C and held for 4.0 hrs, quenched the excess HBr using sodium bicarbonate and filtered through hyflo, to the clear IPA solution containing CoQlO Hydroquinone added ferric chloride 78.Og in water 35 ml, stirred for 3.0hrs and quenched with water and extracted with hexane, washed the hexane layer with water, and dried the hexane layer under sodium sulphate, distilled the hexane under vacuum and obtained a dark red viscous oil which is dissolved in IPA 525ml at 500C and cooled slowly to 250C to get a pale yellow solid which was filtered and washed with sufficient quantity of IPA, recrystallized from ethanol Yield - 41g,Purity - 98%
Advantages
1. CoQlO was obtained in good overall yield as well purity.
2. Purification steps were avoided thereby making the process economical.

Claims

We Claim:
1. A process for the preparation of CoQlO of the formula 1
Figure imgf000019_0001
said process comprising the steps of: i. reacting the Grignard reagent of formula 10
Figure imgf000019_0002
with chloroisoprenyl sulphone of formula 5
Figure imgf000019_0003
in the presence of copper salt and a solvent under inert atmosphere, at a temperature in the range of -25° C to 40° C for a period of 2 to 4 hours, quenching the resultant reaction, extracting the product with a water immiscible solvent to give compound of formula 11,
Figure imgf000019_0004
11. condensing compound of formula ll_with solanesyl bromide of formula 3a
Figure imgf000019_0005
3a in the presence of a base and a solvent at a temperature in the range of - 500C to 500C for a period of 1 to 6 hours to obtain compound of formula 12,
Figure imgf000020_0001
111. desulphonating the compound of the formula 12 using sodium/ethanol in an inert solvent at a temperature in the range of -400C to 200C for a period of 16 to 24 hours to obtain the compound of formula 13,
Figure imgf000020_0002
IV. deprotecting the compound of the formula 13j by HBr or zinc halide / acetic acid in the presence of a chlorinated solvent at a temperature in the range of 15°C to 500C for a period of 2 to 6 hours, quenching the reaction mixture in an aqueous medium and extracting the resulting mixture by a water immiscible solvent, evaporating the solvent to obtain the compound of formula 14,
Figure imgf000020_0003
V. oxidising the compound of formula 14 by conventional method to form compound of formula 1 and
Vl. isolating the compound of formula (1) formed by conventional methods.
2. Improved process for the preparation of chloroisoprenyl sulphone compound of formula 5
Figure imgf000021_0001
useful for the preparation of CoQ10, said process comprising the steps of,
(i) Reacting isoprene of formula 4
Figure imgf000021_0002
4 with benzenesulphonyl chloride and triethylamine hydrochloride in presence of cuprous halide preferably cuprous iodide at a temperature in the range of 400C to 60 ° C in acetonitrile, quenching the resultant reaction, extracting the product with a chlorinated solvent, evaporating the solvent to give compound of formula 5,
(ii) isolating and purifying the compound of formula 5 by conventional methods.
3. Novel intermediate of formula 11
Figure imgf000021_0003
useful for the preparation of CoQlO.
4. Novel intermediate of formula 12
Figure imgf000021_0004
useful for the preparation of CoQlO.
5. A process according to claim 1 for the preparation of novel intermediate of formula 11, said process comprising the steps of: (i) reacting the Grignard reagent of formula 10
Figure imgf000022_0001
with chloroisoprenyl sulphone of formula 5
Figure imgf000022_0002
in the presence of copper salt and a solvent under inert atmosphere, at a temperature in the range of -25° C to 40° C for a period of 2 to 4 hours, quenching the resultant reaction, extracting the product with a water immiscible solvent to give compound of formula 11,
(ii) isolating and purifying the compound of formula 11 formed by conventional methods.
6. A process according to claim 1 for the preparation of novel intermediate of formula 12, said process comprising the steps of: (i) condensing compound of formula 11
Figure imgf000022_0003
with solanesyl bromide of formula 3a
Figure imgf000023_0001
in the presence of a base and a solvent at a temperature in the range of - 500C to 500C for a period of 1 to 6 hours, quenching the resultant reaction, extracting the product with a water immiscible solvent to give compound of formula 12
(ii) isolating and purifying the compound of formula 12 formed by conventional methods.
7. The process as claimed in claims 1 and 5, wherein the copper salt used in step (i) is selected from cuprous chloride, cuprous iodide and cuprous sulfate.
8. The process as claimed in claims 1 and 5, wherein the solvent in step (i) is selected from diethylether, tetrahydrofuan and dioxan.
9. The process as claimed in claims 1 and 6, wherein the base used in step (ii) is selected from potassium tertiary butoxide, sodium ethoxide, sodium hydroxide and potassium hydroxide.
10. The process as claimed in claims 1 and 6, wherein the solvent in step (ii) is selected from N,N dimethyl formamide, tetrahydrofuran and diisopropyl ether.
11. The process as claimed in claim 1, wherein the inert solvent in step (iii) is selected from tetrahydrofuran, diethylether and xylol.
12. The process as claimed in claim 1, wherein the zinc halide in step (iv) is selected from zinc chloride and zinc bromide.
13. The process as claimed in claim 1, wherein the chlorinated solvent used in step (iv) is selected from methylene chloride, chloroform and carbon tetrachloride.
14. The process as claimed in claim 2, wherein the cuprous halide used in step (i) is selected from cuprous chloride and cuprous iodide.
15. The process as claimed in claim 1, wherein the mole ratio of cuprous salt to the Grignard reagent used in step (i) is 1:0.1 to 1:1.0, preferably 1:0.7.
16. The process as claimed in claim 2, wherein in step (i) the molar ratio of benzene sulphonyl chloride and isoprene is in the range of 1:1 to 1:2 preferably 1:1.2 to 1:1.3; molar ratio of benzene sulphonyl chloride to triethylamine hydrochloride is in the range of 1:0.1 to 1:0.2 preferably 1:0.08 to 1:0.15.
PCT/IB2007/051676 2006-05-05 2007-05-04 Novel intermediates, process for their preparation and process for the preparation of coq10 employing the said novel intermediates WO2007129269A2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IN706/MUM/2006 2006-05-05
IN706MU2006 2006-05-05

Publications (2)

Publication Number Publication Date
WO2007129269A2 true WO2007129269A2 (en) 2007-11-15
WO2007129269A3 WO2007129269A3 (en) 2009-04-23

Family

ID=38668160

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/IB2007/051676 WO2007129269A2 (en) 2006-05-05 2007-05-04 Novel intermediates, process for their preparation and process for the preparation of coq10 employing the said novel intermediates

Country Status (1)

Country Link
WO (1) WO2007129269A2 (en)

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
MIN ET AL.: 'The Friedel-Crafts Allylation of a Prenyl Group Stabilized by a Sulfone Moiety.' JOURNAL OF ORGANIC CHEMISTRY vol. 68, 2003, pages 7925 - 7927 *
OLSON ET AL.: 'Vitamin A Synthesis by Sulfone Alkylation-Elimination.' JOURNAL OF ORGANIC CHEMISTRY. vol. 41, no. 20, 1976, pages 3287 - 3293 *
TRUCE ET AL.: 'The Copper-Catalyzed Addition of Arenesulfonyl Chlorides to Conjugated Dienes, Trienes, and Phenylacetylene.' JOURNAL OF ORGANIC CHEMISTRY. vol. 35, no. 12, 1970, pages 4217 - 4220 *

Also Published As

Publication number Publication date
WO2007129269A3 (en) 2009-04-23

Similar Documents

Publication Publication Date Title
EP1910399A2 (en) Novel intermediates, process for their preparation and process for the preparation of coq10 employing the said novel intermediates
JPWO2006006496A1 (en) Method for producing azulene derivatives and synthetic intermediates thereof
KR20050016421A (en) Preparations of a sulfinyl acetamide
EP0150996B1 (en) Manufacture of heptanoic acid derivatives
US20090270639A1 (en) Process for production of (±)-3a,6,6,9a- tetramethyldecahydronaphtho[2,1-b]furan-2(1h)-one
US20080139826A1 (en) Method For Manufacturing Fullerene Derivatives
JP2000034239A (en) Production of trifluoromethylated aromatic compound
US7674614B2 (en) Method of optically resolving racemic alcohols with a bicyclooxaoctane or a bicycooxaoctene resolving reagents
WO2007129269A2 (en) Novel intermediates, process for their preparation and process for the preparation of coq10 employing the said novel intermediates
EP1682526B1 (en) Method for the preparation of citalopram
KR100384982B1 (en) Production method of all trans-type polyphenols
JP2004189696A (en) Method for manufacturing optically active 6,6'-dimethyl-1,1'-biphenyl-2,2'-diol derivative
KR100570279B1 (en) Intermediates of coenzyme qn and process for the preparation thereof
EP0209905B1 (en) 1,1-(3-ethylphenyl)phenylethylene and method for its preparation
KR100713029B1 (en) Process for the preparation of hydroquinone derivatives
JP5000031B2 (en) Method for producing aromatic-o-dialdehyde compound
EP1094053B1 (en) Method of preparing fluoroaromatic compounds
JP5424272B2 (en) Method for producing 9-hydroxymethyl-cyclohepta [b] pyridine-3-carboxylic acid ester derivative
JP3986577B2 (en) Method for producing bifunctional terpenoids
JPS584688B2 (en) Production method of ethynylbenzene derivatives
JP3312414B2 (en) Process for producing dienoic halides
CN116396328A (en) Diaryl phosphono-4-fluoro-1, 3-butadiene phosphate compound and preparation method thereof
WO2007129268A2 (en) Improved process for the synthesis of coq10
US5821387A (en) Polyarenes from aryl ketones with application to synthesis of crisnatol mesylate
CN116836085A (en) Synthesis method of 2-cyano-4, 4-dialkoxy alkyl butyrate

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 07735768

Country of ref document: EP

Kind code of ref document: A2

NENP Non-entry into the national phase in:

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 07735768

Country of ref document: EP

Kind code of ref document: A2